Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.

@article{Schmidt1996Fluorine18fluorodeoxyglucosePT,
  title={Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.},
  author={Kathleen C. Schmidt and Giovanni Lucignani and Louis Sokoloff},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={1996},
  volume={37 2},
  pages={
          394-9
        }
}
ofthe various factors that go into the computation better; it also segregates the least reliable and error-prone model-dependent components into terms that can be identified and minimized. Regional cerebral glucose utilization is calcu lated as: IT C@†• (T) †" K'I' I C@(t) e@ +k@)(Tt) dt JO (IfTC(t) fTC@(t) e@ +k@)(Tt) dt)-@-dt-i; 0 @ 0 Eq.! where C@' represents total concentration of ‘4C in a homoge neous tissue in brain; C and C@are the [‘4C]deoxyglucose and glucose concentrations in… CONTINUE READING
Highly Cited
This paper has 33 citations. REVIEW CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 18 citations

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Measurement of regional cerebral glucose utilization with [ †̃MF ] FDGand PET in heterogeneous tissues : theoretical considerations and practical procedure

  • K chmidt, T Jay
  • J Nucl Med
  • 1993

Spectral analysis of dynamic PET studies

  • MorescoRM TurkheimerF, SokoloffL LucignaniG, SchmidtK FazioF
  • J Cereb Blood Flow Metab
  • 1993

Measurements ofglucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG - 6 - phosphate

  • RA Hawkins, AL Miller
  • J NucIMed
  • 1991